Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test




  • In Business
  • 2021-03-05 23:28:00Z
  • By PR Newswire
Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test
Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test  

Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test

PR Newswire

SILVER SPRING, Md., March 5, 2021

SILVER SPRING, Md., March 5, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect COVID Test developed by Adaptive Biotechnologies. The T-Detect COVID Test is a next generation sequencing based (NGS) test to aid in identifying individuals with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2.

"Today's authorization further underscores the FDA's commitment to innovation in test development," said Jeff Shuren, M.D., J.D., director of FDA's Center for Devices and Radiological Health. "The T-Detect COVID Test is a novel technology that assesses the T cell immune response to COVID-19. Information and scientific data that deepen our understanding of SARS-CoV-2 remain important keys to get ahead of this global pandemic."

The test analyzes DNA (deoxyribonucleic acid) sequences from T cells (white blood cells) to aid in identifying individuals with an adaptive T cell immune response to SARS-CoV-2, indicating recent or previous SARS-CoV-2 infection. A positive test result indicates recent or prior infection with SARS-CoV-2, while a negative test result indicates that a patient is unlikely to have been infected with SARS-CoV-2. Negative results do not preclude acute or current SARS-CoV-2 infection. All results from the test should be used in combination with a clinical examination, patient medical history and other findings. The T-Detect COVID Test should not be used to diagnose current SARS-CoV-2 infection.

A T cell response may be detected in blood several days after initial infection; however, it is unknown how long the T cell immune response remains following infection and what level of protection may be provided by the presence of a T cell immune response. The T-Detect COVID test will be a useful tool to help determine if a person previously had COVID-19. This is especially important for people who may have exhibited symptoms previously or believe they have been exposed but have not tested positive for COVID-19 using a molecular or antigen diagnostic test.

The test is indicated for use by qualified healthcare professionals on samples from individuals who are 15 days or more post-symptom onset. Testing is currently limited to laboratories designated by Adaptive Biotechnologies Corporation that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and meet the requirements to perform high complexity tests.

# # #

Media Contact: Lauren-Jei McCarthy, 240-702-3940

Consumer Inquiries: dice@fda.hhs.gov, 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

View original content to download multimedia:http://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-adaptive-biotechnologies-t-detect-covid-test-301241761.html

SOURCE U.S. Food and Drug Administration

COMMENTS

More Related News

How Cubs responded to Craig Driver
How Cubs responded to Craig Driver's positive COVID-19 test

The Cubs have taken extra precaution this week in wake of first base coach Craig Driver testing positive for COVID-19.

Women report more side effects from the COVID-19 vaccine than men. Health experts explain why.
Women report more side effects from the COVID-19 vaccine than men. Health experts explain why.

Health experts say biological differences between men and women, inconsistent reporting by men and gender bias in clinical trials may be some reasons.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • Mwhqtu
    (2021-03-11 20:34:09Z)

    tadalafil buy online - what is tadalafil 20mg tadalafil professional http://tadalafiltbs.com/

    REPLY
  • Aghtwe
    (2021-03-17 18:30:25Z)

    Hvweal - Sample viagra cheap viagra online canadian pharmacy

    REPLY
  • Zwxdhf
    (2021-03-23 18:05:45Z)

    Zhbcwb - modafinil 200mg Ykuits wbffoz

    REPLY
  • Jmdehw
    (2021-03-24 20:26:51Z)

    Yqqbeu - cialis pas cher livraison rapide Sfybqh dwtenh

    REPLY
  • Lvygit
    (2021-03-25 16:08:13Z)

    Ksiwye - furosempi.com Gltrbc kueqky

    REPLY
  • Hkrbfw
    (2021-03-27 12:32:04Z)

    Mtbnkw - amoxicillin for dogs without vet prescription Jkgxwp hcvipq

    REPLY
  • Wrkotz
    (2021-03-28 11:52:25Z)

    Zsdhuz - buy generic cialis online india Jgugen rujszj

    REPLY
  • Vcswwa
    (2021-03-29 13:49:08Z)

    Ddqdhc - price of viagra 100mg in india Yzemwx mspmtp

    REPLY
  • Rzybvp
    (2021-03-31 00:21:34Z)

    Itibwb - cheap custom essay papers Jmjpxo zrkonf

    REPLY
  • Vhbvwv
    (2021-04-01 15:44:00Z)

    Qeudfc - viagra where to buy Qoovrl goizqf

    REPLY
  • Zwsvgo
    (2021-04-03 05:00:48Z)

    Emytht - research paper on internet Teozei xyooym

    REPLY
  • Zncgjw
    (2021-04-06 22:11:22Z)

    Kkmsoa - propecia nz buy Szauhr drvqlb

    REPLY
  • Icfzpr
    (2021-04-08 15:21:03Z)

    Qakppo - need help with an assignment Ghuplr pbfryv

    REPLY
  • Vzwfwz
    (2021-04-10 07:02:47Z)

    Dungax - buy liquid sildenafil citrate Qvdbge kmjrni

    REPLY
  • Dduxnp
    (2021-04-11 14:27:45Z)

    Hakgsm - essay writing requirements Orynlu dcmomz

    REPLY

Top News: Business